PHENOMEX INC (CELL)

PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding...

PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human...

PhenomeX to Participate in Upcoming Cell Biology Conferences

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, today announced it will showcase their latest optofluidic and proteomic...

PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch of Meteor™ chips on the IsoSpark™ platform,...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOVO, THRN, ABCM, CELL

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CPRI, CEQP, CELL, ZYNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL) today announced that Bruker Corporation (Nasdaq: BRKR) has commenced, through its wholly owned subsidiary, Bird...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMMF, BHRB, ESTE, CELL

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CELL, AEL, RETA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023

CELL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PhenomeX Inc. Is Fair to Shareholders

Shareholder Alert: Ademi LLP investigates whether PhenomeX Inc. has obtained a Fair Price in its transaction with Bruker Corporation

/PRNewswire/ -- Ademi LLP is investigating PhenomeX (NASDAQ: CELL) for possible breaches of fiduciary duty and other violations of law in its transaction with...

Bruker buys PhenomeX for $108M cash (NASDAQ:BRKR)

Bruker (BRKR) said Thursday it will purchase cell biology company PhenomeX (CELL) in a deal valued at $108 million in cash

Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction

Wednesday Sector Laggards: Biotechnology, Trucking Stocks

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023....

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the...

PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the series of lawsuits filed by AbCellera in 2020 will...

PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company's technology was recently featured in a...

PhenomeX neemt deel aan Antibody Engineering & Therapeutics Europe 2023

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), het bedrijf voor functionele celbiologie, heeft vandaag bekendgemaakt van 6-8 juni 2023 in het Postillion Hotel...

PhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling Workflows

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch of the Beacon Quest™ optofluidic system, with...

PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody Engineering & Therapeutics...

PhenomeX nimmt an der Antibody Engineering & Therapeutics Europe 2023 teil

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), das Unternehmen für funktionelle Zellbiologie, gab heute seine Teilnahme an der Antibody Engineering &...